Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / May / Preventing the Next Pandemic
Microbiology & Immunology Infectious Disease Molecular Pathology Screening and monitoring Omics

Preventing the Next Pandemic

Why we must urgently boost biosurveillance for zoonotic pathogens

By Neil Ward 05/07/2025 Discussion 4 min read

Share

According to global health experts, we are living in an “era of pandemics.” COVID-19 was at least the fifth global health pandemic since the Great Influenza Pandemic of 1918. Zoonotic pathogens – disease-causing microorganisms that can spread from animals to humans – pose the greatest threat to global society. Hundreds of thousands, maybe millions, of viruses exist in mammals and birds, many of which could infect people.

Recent years have seen high levels of avian flu, which is mutating and jumping from birds to other animals with an ever-increasing pandemic threat, according to the European Centre for Disease Prevention and Control. Meanwhile, the Coalition for Epidemic Preparedness Innovations has identified seven priority pathogens – including COVID-19, Ebola and Lassa Fever – all of which are zoonotic. 

While the extraordinary global response to the COVID-19 pandemic enabled containment and control of the disease through vaccines and therapeutics, this is not a sustainable approach. Future pandemics may well be more virulent, borne from pathogens significantly more complex to tackle. So, how should the world respond?

To navigate this era of pandemics a seismic shift in mindset and policy is needed – from a reactive to preventative approach that mitigates their spread. 

Genomic sequencing lifts the lid on dangerous pathogens

The good news is that we have the means and the methods available to reduce the impact of zoonotic pandemics. Through modern biosurveillance techniques, we can actively monitor, detect, and analyze zoonotic pathogens and pre-emptively gauge their threat to humans. 

In particular, genomic sequencing has become an invaluable tool to analyze genomic data from a variety of sources to identify potential pathogens and variants. Sources can include animal species known to harbor zoonotic pathogens – such as bats, rodents, primates and livestock – and individuals who work in close contact with animals, such as farmers, veterinarians, and market workers. Samples from these sources can be sequenced to identify mutations and detect new strains. Another useful source of information is wastewater, which can be analyzed to track resistance rates among microbes in local populations. 

The ultimate goal – as characterized by the World Health Organization’s International Pathogen Surveillance Network – is a world where every country has equitable access to genomic sequencing and analytics as part of its public health surveillance system.

However, while governments are starting to expand their biosurveillance of zoonotic pathogens, many are still relying on one type of genomic sequencing technology – called short-read sequencing – to do so. While short-read sequencing has many uses, it analyses a pathogen’s genome in small fragments rather than one long, continual “read”, which can lead to parts of the genome being missed or contribute to high error rates. This, in turn, can lead to incorrect interpretation of the transmission mechanisms of pathogens as well as how they evolve to become drug resistant.

This matters because if we are tackling a pathogen that is more complex than COVID – which was comparatively simple to amplify and sequence – then an early, accurate picture is absolutely essential. 

The time to act is now

To keep the threat of a potentially devastating pandemic at bay, governments urgently need to employ the latest advances in sequencing technology. Modern long-read sequencing technologies enable the sequencing of much longer DNA fragments, simplifying the interpretation of the sequence data and enabling sequencing of variants that current short-read sequencing technology struggles with. Therefore, long-reads enable a much clearer picture and deeper analysis of pathogens and their potential threat. 

The latest generation of accurate long-read sequencers are becoming rapidly more accessible. As advances in the technology bring down cost, it is becoming more feasible to establish large-scale disease surveillance networks for many more nations, enabling a preventative approach to pandemics worldwide. 

Addressing the threat – together

The threat of zoonotic pathogens is increasing. Urbanization is increasing the risk of rapid transmission; meanwhile, climate change is altering the habits of mosquitoes and ticks creating greater opportunity for diseases like malaria, dengue and Lyme disease to spread. 

Now is the time to act. By introducing the latest generation of sequencing technology as part of a national biosurveillance plan, governments can help to identify dangerous zoonotic pathogens before they spread. Alongside technology, international collaboration and data sharing will enable the world to shift towards a preventive approach, avoid global public health crises, and help to make the era of pandemics a thing of the past.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Neil Ward

General Manager EMEA at PacBio, based in Reading, UK.

More Articles by Neil Ward

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Viral Frontier
Infectious Disease
The Viral Frontier

January 23, 2024

1 min read

The latest on the UK COVID-19 inquiry

What’s New in Infectious Disease? (December 2021)
Infectious Disease
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Infectious Disease
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

Pneumocystis Mysteries
Infectious Disease
Pneumocystis Mysteries

January 21, 2022

1 min read

What is the correct name for this pneumonia-causing pathogen?

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.